Renalytix AI plc (RENX) — Working Capital to Net Assets Ratio
Renalytix AI plc (RENX) has a Working Capital to Net Assets ratio of -481.0% as of December 2024. Working capital of GBX6.58 Million (current assets of GBX11.19 Million minus current liabilities of GBX4.61 Million) is measured against net assets of GBX-1.37 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Renalytix AI plc (RENX) flexibility index to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Renalytix AI plc Working Capital to Net Assets (2012–2025)
This chart shows how Renalytix AI plc's Working Capital to Net Assets ratio has evolved across 14 annual periods from 2012 to 2025. As of December 2024, the ratio stands at -481.0%, reflecting working capital of GBX6.58 Million against net assets of GBX-1.37 Million GBX. See defensive interval ratio of Renalytix AI plc to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Renalytix AI plc (2012–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Renalytix AI plc from 2012 to 2025, covering 14 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see RENX stock market capitalisation.
| Year | WC/NA Ratio | Working Capital (GBX) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | -14.3% | GBX1.00 Million | GBX-7.00 Million | GBX5.80 Million | GBX4.80 Million | ▼ -82.7 pp |
| 2024 | 68.5% | GBX-5.38 Million | GBX-7.85 Million | GBX6.12 Million | GBX11.49 Million | ▲ +95.5 pp |
| 2023 | -27.0% | GBX-5.61 Billion | GBX20.76 Billion | GBX17.90 Billion | GBX23.51 Billion | ▼ -85.2 pp |
| 2023 | 58.2% | GBX10.75 Million | GBX18.45 Million | GBX26.88 Million | GBX16.13 Million | ▼ -18.1 pp |
| 2022 | 76.4% | GBX32.98 Million | GBX43.17 Million | GBX44.75 Million | GBX11.78 Million | ▲ +4.1 pp |
| 2021 | 72.3% | GBX68.74 Million | GBX95.10 Million | GBX76.01 Million | GBX7.26 Million | ▲ +29.1 pp |
| 2020 | 43.1% | GBX15.51 Million | GBX35.96 Million | GBX18.90 Million | GBX3.38 Million | ▲ +12.5 pp |
| 2019 | 30.7% | GBX8.64 Million | GBX28.17 Million | GBX9.40 Million | GBX755.00K | ▼ -69.3 pp |
| 2018 | 100.0% | GBX-9.39K | GBX-9.39K | GBX56.63K | GBX66.02K | ▲ +139.3 pp |
| 2016 | -39.3% | GBX-7.02 Billion | GBX17.87 Billion | GBX14.61 Billion | GBX21.64 Billion | ▲ +6.3 pp |
| 2015 | -45.6% | GBX-7.96 Billion | GBX17.47 Billion | GBX13.78 Billion | GBX21.74 Billion | ▲ +5.5 pp |
| 2014 | -51.1% | GBX-8.83 Billion | GBX17.26 Billion | GBX14.95 Billion | GBX23.78 Billion | ▼ -15.6 pp |
| 2013 | -35.5% | GBX-7.24 Billion | GBX20.40 Billion | GBX16.69 Billion | GBX23.94 Billion | ▼ -12.5 pp |
| 2012 | -23.0% | GBX-4.84 Billion | GBX21.03 Billion | GBX16.02 Billion | GBX20.85 Billion | — |